Determination of affinities of a panel of IgGs and Fabs for whole enveloped (influenza A) virions using surface plasmon resonance

[1]  Q. Sattentau,et al.  Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer , 1995, The Journal of experimental medicine.

[2]  J. Casasnovas,et al.  Kinetics and Thermodynamics of Virus Binding to Receptor. , 1995, The Journal of Biological Chemistry.

[3]  P. Talbot,et al.  Protection from lethal coronavirus infection by immunoglobulin fragments. , 1995, Journal of immunology.

[4]  M. O’Connor-McCourt,et al.  Evidence of a major neutralizable conformational epitope region on VP2 of infectious pancreatic necrosis virus. , 1995, The Journal of general virology.

[5]  D R Burton,et al.  Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure. , 1995, Journal of immunology.

[6]  C. Barbas,et al.  Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120 , 1995, Journal of virology.

[7]  G. Zeder‐Lutz,et al.  Cross-reactivity of monoclonal antibodies to a chimeric V3 peptide of HIV-1 with peptide analogues studied by biosensor technology and ELISA. , 1994, Journal of immunological methods.

[8]  J. Grosclaude,et al.  Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein , 1994, Journal of virology.

[9]  D R Burton,et al.  Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. , 1994, Science.

[10]  J. Grosclaude,et al.  Topology of bovine rotavirus (RF strain) VP6 epitopes by real-time biospecific interaction analysis. , 1994, Virology.

[11]  C. Bourgeois,et al.  Biological activity, binding site and affinity of monoclonal antibodies to the fusion protein of respiratory syncytial virus. , 1994, The Journal of general virology.

[12]  D R Burton,et al.  Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1 , 1994, Journal of virology.

[13]  John E. Johnson,et al.  Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides. , 1994, Virology.

[14]  S. Zolla-Pazner,et al.  Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1. , 1994, Journal of immunology.

[15]  D R Burton,et al.  In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Emini,et al.  Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Mani,et al.  Effect of HIV-1 peptide presentation on the affinity constants of two monoclonal antibodies determined by BIAcore technology. , 1994, Molecular immunology.

[18]  L. Cavacini,et al.  Effect of antibody valency on interaction with cell-surface expressed HIV-1 and viral neutralization. , 1994, Journal of immunology.

[19]  C. Bourgeois,et al.  Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli. , 1993, The Journal of general virology.

[20]  M. V. Van Regenmortel,et al.  Measurement of kinetic binding constants of viral antibodies using a new biosensor technology. , 1993, Journal of immunological methods.

[21]  P. Andrews,et al.  Verification of the interaction between peptide T and CD4 using surface plasmon resonance , 1993, FEBS letters.

[22]  E. Nice,et al.  Determination of relative binding affinity of influenza virus N9 sialidases with the Fab fragment of monoclonal antibody NC41 using biosensor technology. , 1993, European journal of biochemistry.

[23]  R. Redfield,et al.  Measurement of cerebrospinal fluid antibody to the HIV-1 principal neutralizing determinant (V3 loop). , 1993, Journal of acquired immune deficiency syndromes.

[24]  J. Bye,et al.  Human anti‐self antibodies with high specificity from phage display libraries. , 1993, The EMBO journal.

[25]  D R Burton,et al.  Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. O'Shannessy,et al.  Detection of receptor-ligand interactions using surface plasmon resonance: model studies employing the HIV-1 gp120/CD4 interaction. , 1992, Analytical biochemistry.

[27]  M Ohlin,et al.  Real Time Analysis of Antibody‐Antigen Reaction Kinetics , 1992, Scandinavian journal of immunology.

[28]  D. Altschuh,et al.  Mapping of viral epitopes with conformationally specific monoclonal antibodies using biosensor technology. , 1992, Journal of chromatography.

[29]  R. Redfield,et al.  Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, gp160, of HIV-1. , 1992, Journal of immunological methods.

[30]  D. Altschuh,et al.  Interaction between viruses and monoclonal antibodies studied by surface plasmon resonance. , 1992, Immunology letters.

[31]  Kevin Welford,et al.  Surface plasmon-polaritons and their uses , 1991 .

[32]  A. Douglas,et al.  Specific structural alteration of the influenza haemagglutinin by amantadine. , 1990, The EMBO journal.

[33]  V. Neuhoff,et al.  Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G‐250 and R‐250 , 1988, Electrophoresis.

[34]  N. Dimmock,et al.  Quantitative relationships between an influenza virus and neutralizing antibody. , 1987, Virology.

[35]  P. Parham.  On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice. , 1983, Journal of immunology.

[36]  A. D. Boardman,et al.  Electromagnetic surface modes , 1982 .

[37]  R. Porter.  Antibody molecule , 1975, Nature.

[38]  N. Dimmock,et al.  Fowl plaque virus replication in mammalian cell-avian erythrocyte heterokaryons: studies concerning the actinomycin D and ultra-violet light sensitive phase in influenza virus replication. , 1974, Virology.

[39]  F. Karush,et al.  Antibody affinity—III the role of multivalence , 1972 .

[40]  L. Clem,et al.  Antibody affinity and valence in viral neutralization. , 1972, Journal of immunology.